Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
Piotr DomańskiJadwiga JarosińskaBarbara KruczykMateusz PiętakAnna MydlakTomasz DemkowŁukasz KuncmanMarta DarewiczBożena Sikora-KupisWojciech MichalskiJakub KucharzPublished in: Contemporary oncology (Poznan, Poland) (2024)
Lower PIV and obesity are associated with longer OS in geriatric mRCC patients treated with TKIs in the first line. These factors may be considered while making treatment decisions if further studies show the same results.